Published Oct 10, 2024

What’s the Biggest Threat to the U.S. Economy’s Soft-Landing? — ft. Mark Zandi | Prof G Markets

Join Ed Elson and Scott Galloway as they delve into Starboard Value's bold $1 billion move in Pfizer while economist Mark Zandi provides a comprehensive analysis of the U.S. economic outlook, evaluating the potential for a soft landing amidst looming deficits and electoral uncertainties.
Episode Highlights
Prof G Markets logo

Popular Clips

Questions from this episode

Episode Highlights

  • Pfizer Investment

    Starboard Value's recent investment in Pfizer has sparked discussions about the effectiveness of activist investing. and highlight that Starboard's $1 billion stake represents less than 1% of Pfizer's market cap, questioning its potential impact 1. Despite this, the move has already influenced Pfizer's stock, which rose by 3% following the announcement 2. Galloway notes a broader trend of capital shifting from vaccine-related treatments to GLP-1 treatments, impacting companies like Moderna and Pfizer 2.

       

    Activist Strategies

    Activist investors like Starboard often employ strategic arguments to influence corporate decisions without holding a controlling stake. Galloway explains that successful activist campaigns, such as those involving Salesforce, rely on compelling arguments for cost-cutting and focus, rather than sheer ownership 3. He emphasizes the importance of timing and leverage, as seen in the Longshoremen's strike, which secured a significant wage increase due to strategic timing and industry growth 4. This reflects the nuanced dynamics of activist investing, where influence often outweighs ownership.

Related Episodes